Ombitasvir Completed Phase 3 Trials for Hepatitis C Viral Infection Other

IndicationsStatusPurposePhase
CompletedOther3
clinicaltrials.gov IdentifierTitleDrugs
NCT01773070A Follow up Study Designed to Obtain Long Term Data on Participants Who Either Achieved a Sustained Virologic Response or Did Not Achieve a Sustained Virologic Response in an AbbVie Sponsored Hepatitis C Study